Results from a health economic substudy of the TRITON-TIMI 38 clinical trial showed that among patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI), including stenting, treatment with Effient(®) (prasugrel) compared with branded clopidogrel (Plavix(®)) was more cost effective, and in most cases cost saving. These results were published in Circulation on [...]

BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced today the introduction of SecuriVAX(SM) (http://www.securivax.com), an online supply solution providing the healthcare community a one-stop source for a wide variety of vaccines. As a result of its representation of multiple brands and indications, SecuriVAX allows customers the convenience of purchasing their [...]

Phadia Inc., worldwide leaders in the development, manufacturing and marketing of complete blood test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases, announced the launch of a two new, highly -reliable assays to support the accurate diagnosis of celiac disease.

Minimizing diagnostic error in medicine is an essential component of safe patient care, a theme to be explored by the physicians, medical scientists, safety officers, risk managers, and educators who will convene at the 2nd Annual Diagnostic Error in Medicine Conference, to be held at the Renaissance Hollywood Hotel on October 21-22 in Los Angeles. [...]

Basilea Pharmaceutica Ltd. (SWISS: BSLN) announces that the National Institute for Health and Clinical Excellence (NICE) issued its final guidance recommending the use of Toctino® (alitretinoin) within its licensed indication, as a treatment option for adults with severe chronic hand eczema that has not responded to potent topical corticosteroids.